Catherine C.

Catherine C. is an accomplished clinical operations professional currently serving as the Director of Clinical Operations at Gilead Sciences since January 2024. With extensive experience in the biopharmaceutical industry, Catherine has held key positions including Global Clinical Operations Program Director for various clients, including Astra Zeneca, and Director of Clinical Development & Operations at Pfizer from August 2020 to August 2022. Previous roles also include Director at AbbVie, where responsibilities encompassed the Investigator Sponsored Trial and Collaborative Research Program, as well as roles at Bellicum Pharmaceuticals, Calene Clinical Sciences, EMD Serono, MD Anderson Cancer Center, and Syneos Health. Catherine holds a Master of Science in Regulatory Science from The Johns Hopkins University and a Bachelor of Science in Molecular Biology from the University of Waterloo, complemented by a robust educational background including completion of the Ontario Secondary School Diploma from Trinity College School and the HKCEE from St. Paul’s Convent School in Hong Kong.